IRWD
IRONWOOD PHARMACEUTICALS INC
IRONWOOD PHARMACEUTICALS INC (IRWD) has 11 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 22, 2026.
Insiders have net sold $21.2M over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Thomas A. McCourt
- Employees:100
- HQ:Boston, MA, US
- IPO:2010-02-03
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$21.2M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$614.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Silver RonaldFirst filing | PFO & PAO | Sale | 127,890 | $578K | Jul 9 | SEC ↗ |
McHugh JulieFirst filing | Director | Sale | 21,571 | $80K | Jun 17 | SEC ↗ |
DENNER ALEXANDER JFirst filing | Director | Sale | 6,730,800 | $20.5M | Mar 17 | SEC ↗ |
Related companies
IRONWOOD PHARMACEUTICALS INC is in the Healthcare sector.